Food Allergen Labelling: A Practical Compliance Guide for Canada and the United States

Food allergen labelling is a product-safety and regulatory-control issue, not simply a packaging task. An inaccurate ingredient statement, an undeclared allergen in a seasoning blend, or an unjustified precautionary statement can expose allergic consumers to harm and create serious compliance, recall, customer-service, and brand-risk consequences.

For manufacturers, importers, co-packers, foodservice operators selling packaged foods, and digital food platforms, allergen information should be controlled from supplier approval through formulation, production, packaging, and final label release. This is especially important for businesses supplying both Canada and the United States, where the priority allergen frameworks and label terminology are similar in purpose but not identical.

This guide explains the core concepts that food businesses should understand when developing and reviewing allergen labels for the Canadian and U.S. markets. It is based on guidance from the Canadian Food Inspection Agency (CFIA), Health Canada, and the U.S. Food and Drug Administration (FDA). It is not legal advice; businesses should verify current requirements against the applicable official guidance and assess product-specific circumstances before market release.

Why allergen labelling requires a system, not a final artwork check

Allergen errors often begin well before a label is designed. Common root causes include:

• A supplier changes a sub-ingredient without timely notification.
• A purchasing team approves an alternative ingredient that does not match the approved formula.
• A recipe uses a compound ingredient, processing aid, or rework material that has not been assessed properly.
• Product and packaging changeovers create cross-contact risks.
• A label file is reused for a similar product with different allergen content.
• An online menu, marketplace listing, or product-data feed is not updated when the physical package changes.
• A precautionary allergen statement is added as a substitute for effective manufacturing controls.

A strong allergen program links product information to operational reality. The declared allergen status must reflect the actual ingredients, the actual manufacturing environment, and the actual finished-product packaging.

The central principle: declare allergens that are present as ingredients

In both Canada and the United States, allergen labelling requirements focus on the clear declaration of specified allergens when they are present in a food. The applicable declaration should be understandable to consumers and consistent with the rules of the market where the food is sold.

The FDA explains that U.S. food allergen labelling rules apply to foods regulated under the Federal Food, Drug, and Cosmetic Act and require major food allergens to be declared when present. FDA identifies nine major food allergens: milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame.

In Canada, CFIA and Health Canada information addresses priority food allergens, gluten sources, and added sulphites. Canadian guidance identifies priority allergens as peanuts, tree nuts, sesame seeds, milk, eggs, fish, crustaceans and shellfish, soy, wheat, and mustard. Canadian requirements also address gluten sources and added sulphites in the circumstances described in the applicable rules and guidance.

The operational takeaway is straightforward: do not assume that a compliant U.S. label is automatically suitable for Canada, or that a Canadian label can be copied unchanged for the U.S. market. Conduct a jurisdiction-specific review for every stock-keeping unit (SKU).

Canada and United States: key allergen-labelling considerations

This table is a high-level operational comparison, not a substitute for a formal regulatory review. Ingredient names, compound ingredients, exemptions, product categories, and presentation requirements can affect the correct label outcome.

Build an allergen inventory before writing the label

The most reliable starting point is an allergen inventory, sometimes called an allergen matrix. This is a controlled record that identifies every ingredient, sub-ingredient, processing input, rework stream, and packaging-related variable that may affect allergen declarations.

A useful allergen inventory should include:

1. Ingredient identity: approved ingredient name, supplier, supplier code, and specification revision.
2. Ingredient composition: full sub-ingredient list, including flavour carriers, seasoning components, and compound ingredients.
3. Allergen status: allergens intentionally present in the ingredient.
4. Cross-contact information: supplier statements concerning potential cross-contact, assessed in context rather than copied automatically onto a finished product label.
5. Market status: whether the ingredient and its naming are appropriate for Canada, the United States, or both.
6. Formula linkage: formula version, bill of materials, and product SKU.
7. Supporting evidence: current specification, certificate or declaration where relevant, and supplier change-notification commitments.

Practical example: seasoning blend risk

A snack manufacturer purchases a “smoky barbecue seasoning” from an approved supplier. The purchase description may appear simple, but the seasoning could contain multiple sub-ingredients, such as spices, sugar, flavours, yeast extract, mustard, soy-containing components, or milk-derived ingredients. The finished snack label cannot be approved based solely on the trade name “smoky barbecue seasoning.”

The manufacturer needs the current composition and allergen information for the blend, then must verify that the finished-product ingredient list and allergen declaration reflect the approved formula. If the supplier reformulates the blend, the label assessment must be repeated before the revised ingredient is used.

Ingredient lists and allergen declarations must agree

A common label-control weakness is treating the ingredient list and the allergen statement as separate content streams. They should be reviewed together.

In the United States, FDA guidance explains that major food allergens may be declared in the ingredient list using the common or usual name of the allergen source, or through a separate “Contains” statement that follows or is adjacent to the ingredient list. The precise approach depends on the ingredient and how it is named.

For example, a U.S. product containing casein should be assessed to ensure that milk is declared in a manner that meets FDA expectations. Similarly, a food containing a tree nut should identify the specific nut type where required by FDA’s allergen labelling approach.

In Canada, CFIA guidance emphasizes the need for clear allergen information and provides examples of how priority allergens, gluten sources, and added sulphites may be declared. Businesses should verify whether an allergen source is already clearly identified in the ingredient list or whether a separate declaration is necessary under the Canadian rules applicable to the product.

Label-review rule: never rely on a generic internal category

Terms such as “dairy,” “shellfish,” “nuts,” or “gluten” may be useful in internal risk assessments, but they are not automatically appropriate consumer-facing declarations. Label text should be assessed against the market-specific requirements and the actual source ingredient.

A robust review asks:

• Is every intentional allergen source identified from the formula and supplier documentation?
• Are all relevant sub-ingredients included in the assessment?
• Does the ingredient list use acceptable naming for the market?
• Does a separate allergen statement, if used, match the ingredient list exactly?
• Has the label been checked against the latest approved formulation and supplier specifications?
• Is the package language consistent across all pack sizes, formats, and online product records?

Cross-contact is different from an allergen ingredient

An allergen intentionally used as an ingredient is not the same as unintended allergen cross-contact. The distinction matters because the control strategy is different.

Intentional presence means the allergen is part of the formula. It must be declared as required for the destination market.

Cross-contact occurs when an allergen is unintentionally introduced into a food, such as through shared equipment, airborne powder transfer, utensils, employee practices, rework, storage errors, or inadequate sanitation between products.

Cross-contact risk should be assessed through a documented allergen-control program. Useful controls may include:

• Supplier approval and ingredient segregation.
• Dedicated or controlled storage locations.
• Clear allergen identification on containers and work-in-process materials.
• Production scheduling that considers allergen sequence.
• Validated or verified cleaning practices, as appropriate to the process.
• Controlled rework rules.
• Line-clearance procedures before packaging changes.
• Staff training in ingredient handling and label verification.
• Final packaging checks to prevent wrong-label or wrong-film incidents.

The appropriate controls depend on the facility, food type, equipment design, cleaning method, allergen properties, and product flow. A dry powder operation, for example, may have different transfer risks from a closed liquid-processing system.

Precautionary allergen statements: use only after risk assessment

Statements such as “may contain,” “may contain traces of,” or “manufactured in a facility that also processes” are commonly described as precautionary allergen labelling. These statements can be important consumer information when a residual cross-contact risk cannot be eliminated despite appropriate controls. However, they should not be used as a blanket legal disclaimer or as a substitute for good manufacturing practices.

CFIA’s industry guidance addresses precautionary allergen statements and emphasizes the importance of managing allergen risks. Food businesses should not apply a precautionary statement merely because an allergen exists somewhere in the facility or because a supplier has issued a broad statement without product-specific evaluation.

A defensible decision process should include:

1. Identifying the source of potential cross-contact.
2. Assessing the likelihood and practical route of transfer.
3. Reviewing preventive controls, including segregation, scheduling, sanitation, and label controls.
4. Determining whether the risk can be eliminated or adequately controlled.
5. Documenting the rationale for any precautionary statement.
6. Reviewing the statement when formulas, suppliers, equipment, schedules, or sanitation methods change.

Poor versus better practice

Overuse of precautionary statements can reduce their value for consumers and may indicate that the underlying food-safety system needs improvement.

The label approval workflow food businesses should implement

A formal label approval workflow prevents many avoidable errors. It should be integrated with research and development, procurement, quality assurance, regulatory affairs, operations, and packaging.

1. Approve the formula and ingredient specifications

Do not begin final label approval until the formulation and all ingredient specifications are current. Every formula component should have an approved supplier and documented allergen profile.

2. Create a market-specific allergen assessment

Assess the product separately for Canada and the United States when it will be sold in both markets. Flag differences in priority or major allergen categories, ingredient naming, and presentation requirements.

3. Generate controlled label text

Create the ingredient list and allergen declaration from the approved formula and specification data, not from an old package file. This reduces copy-and-paste errors.

4. Conduct cross-functional review

Quality, regulatory, and product-development personnel should review allergen information before artwork release. Operations should confirm that the label reflects the actual production environment and packaging configuration.

5. Approve artwork and packaging components

Verify every package format, including retail bags, cartons, multipacks, foodservice packs, sleeves, stickers, and promotional formats. Packaging-component control is essential because a correct label in the artwork system can still fail if the wrong film or carton is issued to the line.

6. Verify at production start-up and changeover

Line personnel should confirm the correct packaging is present before production begins and after changeovers. This is one of the most important points for preventing undeclared-allergen incidents caused by label mix-ups.

7. Maintain change control

Reassess allergen labelling whenever there is a change to ingredients, suppliers, formulations, processing steps, rework practices, production lines, packaging, or market destination.

Special attention areas for restaurants, private labels, and digital channels

Allergen information does not stop at the factory gate.

Restaurants and foodservice businesses

Restaurants may manage frequent recipe changes, substitutions, shared preparation surfaces, and variable supplier availability. Although packaged-food labelling rules may not apply in the same way to every foodservice transaction, the safety principle remains: staff should not guess about allergens.

Maintain current recipe specifications, supplier information, and an internal allergen matrix. Establish a clear escalation process so front-of-house staff can obtain reliable answers rather than providing assumptions to guests.

Private-label and co-manufactured products

Brand owners should not assume the co-manufacturer alone owns allergen-label accuracy. Agreements should define who approves formulas, receives supplier-change notifications, authorizes artwork changes, verifies production labels, and manages market-specific regulatory review.

E-commerce and product-data systems

Online ingredient and allergen information should be governed through the same approved source of truth as package artwork. If a package is reformulated, the website, marketplace listing, distributor data feed, and digital menu should be updated through controlled change management.

Common allergen-labelling failures and how to prevent them

Failure: relying on outdated supplier information

Prevention: Set review dates for specifications, require supplier change notification, and prevent purchasing of unapproved alternates without quality and regulatory assessment.

Failure: missing allergens in compound ingredients

Prevention: Require complete sub-ingredient disclosure for every compound ingredient and flavour system used in the formula.

Failure: packaging mix-ups

Prevention: Use barcode verification, documented line clearance, reconciliation procedures, and start-up checks for every packaging run.

Failure: inconsistent labels across channels

Prevention: Manage physical packaging, product-information management data, e-commerce listings, and foodservice documentation through controlled master data.

Failure: vague precautionary statements

Prevention: Apply precautionary statements only after a documented cross-contact assessment and review whether process improvements can reduce the need for them.

FAQ

What is the difference between an allergen ingredient and cross-contact?

An allergen ingredient is intentionally included in the formula. Cross-contact is unintended allergen presence caused by shared equipment, handling, storage, rework, or other process pathways. Intentional ingredients require appropriate declaration; cross-contact requires risk assessment and preventive controls.

Can a product use a “Contains” statement instead of listing allergens in ingredients?

In the United States, FDA guidance describes ways major food allergens may be declared, including through ingredient-list naming or a separate “Contains” statement in the required location. The correct approach depends on the ingredient and label wording. In Canada, businesses should review CFIA and Health Canada guidance to determine the appropriate declaration for the product.

Is “may contain” required whenever allergens are handled in the same facility?

No. A shared facility alone does not automatically determine the correct precautionary statement. The business should assess actual cross-contact risk and the effectiveness of controls. CFIA guidance makes clear that precautionary statements should not replace proper allergen management.

Can a supplier’s allergen statement be copied directly onto a finished-product label?

Not without assessment. Supplier information is an input to the finished-product risk assessment, but the finished-product label must reflect the product’s own formula, process, and applicable market requirements.

When should an allergen label be reviewed?

Review it before initial launch and whenever ingredients, suppliers, formulations, processing methods, packaging, manufacturing locations, or market destinations change.

Conclusion: treat allergen data as controlled product data

Reliable allergen labelling depends on disciplined product information management. The most effective programs connect supplier specifications, formulas, allergen risk assessments, packaging approvals, production checks, and digital product data in one controlled workflow.

For organizations operating across Canada and the United States, the safest approach is to assess each SKU against the applicable jurisdiction rather than relying on a one-label-fits-all assumption. Keep clear evidence for every allergen decision, review labels whenever product data changes, and ensure precautionary statements are supported by an actual cross-contact assessment.

IntRest can help food businesses structure allergen data, centralize ingredient intelligence, support market-specific label reviews, and maintain consistent product information across packaging and digital channels. For more information, check https://app.intrest.ca and https://enterprise.intrest.ca.